Lava Therapeutics

Creates and develops next generation γδ T cell engaging bispecific antibodies for the treatment of cancer. Learn more

Launch date

2016

Employees

Market cap

Enterprise valuation

($36m) (Public information from Sep 2024)

Company register number 65335740

Utrecht Utrecht (HQ), Amsterdam North Holland (founding location)

https://lavatherapeutics.com/

https://twitter.com/lavatx https://www.linkedin.com/company/lavatherapeutics/

View job openings

Authorizing premium user...